New techniques for assessment of occupational respiratory diseases

Bratislava Medical Journal

Volumn 109, Issue 10, 2008, Pages 445-452

  Gergelova, P ^a   Corradi, M ^b   Acampa, O ^b   Goldini, M ^b   Mutti, A ^b   Franchini, I ^b   Marcinkova, D ^a   Rusnak, M ^a  

^a TRNAVA UNIVERSITY   (Slovakia)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Biomarkers; Non invasive methods; Occupational respiratory diseases

Indexed keywords

NITRIC OXIDE;

ASTHMA; BREATH ANALYSIS; CHEMISTRY; CYTOLOGY; HUMAN; OCCUPATIONAL DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; SPUTUM;

ASTHMA; BREATH TESTS; HUMANS; NITRIC OXIDE; OCCUPATIONAL DISEASES; RESPIRATORY TRACT DISEASES; SPUTUM;

EID: 62649174174     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Beckett WS. Occupational respiratory diseases. New Engl J Med 2000; 10: 406-413.
2. McDonald JC, Chen Y, Zekveld C, Cherry NM. Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med 2005; 62: 836-842.
3. Mutsaers SE, Harrison NK, McAnulty RJ, Liao JY, Laurent GJ, Musk AW. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF, IGF-1, or IL-1. J Pathol 1998; 185: 199-203.
4. Hurbankova M, Cerna S, Gergelova P, Wimmerova S. Influence of refractory fibres asbestos substitute on selected parameters of BAL lavage 6 months after intratracheal instillation to W-rats. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149 (2): 367-371.
5. Fireman E, Lerman Y. Induced sputum in occupational lung diseases. Breathe 2005; 2: 50-59.
6. Mutti A, Corradi M. Recent developments in human biomonitoring: non-invasive assessment of target tissue dose and effects of pneumotoxic metals. Med Lav 2006; 97 (2): 199-206.
7. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Amer J Resp Crit Care Med 2007; 175: 222-227.
8. Djukanovic R. Induced sputum: a tool with great potential but not without problems. J Allergy Clin Immunol 2000; 105: 1071-1073.
9. Kharitonov SA, Barnes JP. Nitric oxide in exhaled air is a new marker of airway inflammation. Monaldi Arch Chest Dis 1996; 51: 533.
10. Horvath I, Hunt J, Barnes JP et al. ATS/ERS Task Force on Exhaled Breath Condensate: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Resp J 2005; 26: 523-548.
11. Corradi M, Mutti A. Exhaled breath analysis: from occupational to respiratory medicine. Acta Biomed Ateneo Parmense 2005; 76: 20-29.
12. Pizzichini MM, Popov TA, Efthimiadis A et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Amer J Resp Crit Care Med 1996; 154: 866-869.
13. Fireman EM, Lerman Y, Ganor E et al. Induced sputum assessment in New York City fire-fighters exposed to World Trade Centre dust. Envion Health Perspect 2004; 112: 1564-1569.
14. Belda J, Leigh J, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Amer J Resp Crit Care Med 2000; 161: 475-478.
15. Djukanovic R. Induced sputum. PCCU 2004;16 [online: http://www.chestnet.org/education/online/pccu/vol16/lessons3_4/ lesson04.php].
16. Kips JC, Peleman RA, Pauwels RA. Methods of examining induced sputum: do differences matter? Europ Resp J 1998; 11: 529-533.
17. Girard F, Chaboillez S, Cartier A et al. An effective strategy for diagnosing occupational asthma; Use of induced sputum. Amer J Resp Crit Care Med 2004; 170: 845-850.
18. Lemiere C, Pizzichini MM, Balkissoon R et al. Diagnosing occupational asthma: use of induced sputum. Europ Resp J 1999; 13: 482-488.
19. Lemiere C. Diagnosing occupational asthma: insight from induced sputum. Canad J Physiol Pharmacol 2006; 84: 1-4.
20. Asthma and allergy research group: Sputum induction testing. [online: http://www.asthma-allergy-research.co.uk/welcome.html]
21. Maestrelli P, Calcagni PG, Saetta M et al. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy 1994; 24: 29-34.
22. Gibson PG. Use of induced sputum to examine airway inflammation in childhood asthma. J Allergy Clin Immunol 1998; 102: S100-S101.
23. Bernstein IL, Bernstein DI, Chan-Yeung M, Malo JL. Definition and classification of asthma. 1-3. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI (Eds). Asthma in the workplace. New York; Marcel Dekker, 1999.
24. Lemiere C. The use of sputum eosinophils in the evaluation of occupational asthma. Curr Opin Allergy Clin Immunol 2004; 4: 81-85.
25. Park HS, Kim HA, Jung JW et al. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate induced asthma. Clin Exp Allergy 2003; 33: 113-118.
26. Lemiere C, Pelissier S, Tremblay C et al. Leukotrienes and isocyanate-induced asthma: a pilot study. Clin Exp Allergy 2004; 34: 1684-1689.
27. Rosenberg G, Harrison R. Biological Monitoring. 637-646. In: La Dou J (Ed). Occupational and Environmental Medicine. New York; Appleton and Lange, 1997.
28. Paris C, Galateau-Salle F, Creveuil C et al. Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure. Eur Resp J 2002; 20: 1167-1173.
29. Marek W, Kotschy-Lang N, Muti A et al. Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers. Eur Resp J 2001; 18: 942-950.
30. Fireman E, Greif J, Schwarz Y et al. Assessment of hazardous dust exposure by BAL and induced sputum. Chest 1999; 115: 1720-1728.
31. Akpinar-Elci M, Stemple KJ, Enright PL et al. Induced sputum evaluation in microwave popcorn production workers. Chest 2005; 128: 991-997.
32. Nordenhäll C, Pourazar J, Blomberg A, Levin JO, Sadndström T, Ädelroth E. Airway inflammation following exposure to diesel exhaust: a study of time kinetics using induced sputum. Eur Resp J 2000; 15: 1046-1051.
33. Dragonieri S, Musti M, Izzo C et al. Sputum induced cellularity in a group of traffic policemen. Sci Total Environ 2006; 367: 433-436.
34. Redington AE, Meng QH, Springall DR et al. Increased expression of inducible nitric oxide sythase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001; 56: 351-357.
35. Ricciardolo FLM, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and diseases of the respiratory system. Physiol Rev 2004; 84: 731-765.
36. Lanz MJ, Leung DYM, White CW. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Chest 1999; 82: 161-164.
37. Yates DH. Role of exhaled nitric oxide in asthma. Immunol Cell Biol 2001; 79: 178-190.
38. Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG. Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-·-induced nintric oxide production by rat alveolar macrophages. Agents Actions 1993; 38: 100-105.
39. Hamad AM, Johnson SR, Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Amer J Physiol Lung Cell Mol Physiol 1999; 277: L910-L918.
40. Silkoff PE. Exhaled nitric oxide as a diagnostic tool. Amer J Resp Crit Care Med 2003; 167 (4): 665-666.
41. Lemiere C. Induced sputum and exhaled nitric oxide as non-invasive markers of airway inflammation from work exposures. Curr Opin Allergy Clin Immunol 2007; 7 (2): 133-137.
42. Swierczynska-Machura D, Krakowiak A, Wiszniewska M, Palczynski C. Diagnostic of occupational asthma: measurements of exhaled nitric oxide. Med Pr 2005; 56 (6): 485-490.
43. Piipari R, Piirila P, Keskinen H, Tuppurainen M, Sovijarvi A, Nordman H. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Resp J 2002; 20 (6): 1532-1537.
44. Menzies D, Nair A, Williamson PA et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. J Amer Med Ass 2006; 296 (14): 1778-1779.
45. Olin AC, Andersson E, Andersson M, Granung G, Hagberg S, Toren K. Prevalence of asthma and exhaled nitric oxide are increased in bleachery workers exposed to ozone. Eur Resp J 2004; 23 (1): 87-92.
46. Olin AC, Ljungkvist G, Bake B, Hagberg S, Henriksson L, Toren K. Exhaled nitric oxide among pulpmill workers reporting gassing incidents involving ozone and chlorine dioxide. Eur Resp J 1999; 14 (4): 828-831.
47. Lund MB, Oksne PI, Hamre R, Kongerud J. Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers? Occup Environ Med 2000; 57 (4): 274-278.
48. Barbinova L, Baur X. Increase nitric oxide (eNO) after work-related isocyanate exposure. Int Arch Occup Environ Health 2006; 79: 387-395.
49. Baur X, Barbinova L. Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers. Eur Resp J 2005; 25: 309-316.
50. Maniscalco M, Grieco L, Galdi A, Lundberg JO, Sofia M. Increase in exhaled nitric oxide in shoe and leather workers at the end of the work-shift. Occup Med (Lond) 2004; 54 (6): 404-407.
51. Lehtonen H, Oksa P, Lehtimäki L et al. Increased alveolar nitric oxide concentration, and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 2007; [Epub ahead of print] 445-452
52. Tan K, Bruce C, Birkhead A, Thomas PS. Nasal and exhaled nitric oxide in response to occupational latex exposure. Allergy 2001; 56 (7): 627-632.
53. Akpinar-Elci M, Stemple KJ, Elci OC, Dweik RA, Kreiss K, Enright PL. Exhaled nitric oxide measurement in workers in a microwave popcorn production plant. Int J Occup Environ Health 2006; 12 (2): 106-110.
54. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006; 130: 1541-1546.
55. Corradi M. Il condensato dell'aria espirata. 102-103. In: Mutti A, Goldoni M (Eds). Medicina del lavoro: tra aquisizioni e nuove frontiere Parma; Monte Universitá Parma, 2005.
56. Mutti A, Corradi M, Goldoni M, Vettori MV, Bernard A, Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006; 129: 1288-1297.
57. Hunt J. Exhaled breath condensate: An evolving tool for non-invasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110 (1): 28-34.
58. Corradi M, Pignatti S, Manini P et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Resp J 2004; 24 (6): 1011-1117.
59. Profita M, La Grutta S, Carpagnano E et al. Non-invasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006; 118 (5): 1068-1074.
60. Montuschi P, Kharitonov SA, Ciabattoni G, Barnes JP. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58: 585-588.
61. Goldoni M, Catalani S, De Palma G et al. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environ Health Perspect 2004; 112 (13): 1293-1298.
62. Goldoni M, Caglieri A, Poli D et al. Determination of hexavalent chromium in exhaled breath condensate and environmental air among chrome plating workers. Anal Chim Acta 2006; 562 (2): 229-235.
63. Caglieri A, Goldoni M, Acampa O et al. The effect of inhaled chromium on different exhaled breath condensate biomarkers among chrome-plating workers. Environ Health Perspect 2006; 114 (4): 542-546.
64. Maniscalco M, De Laurentii G, Pentella C et al. Exhaled breath condensate as matrix for toluene detection: a preliminary study. Biomarkers 2006; 11 (3): 233-240.